• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动:当前的流行疾病

Atrial fibrillation: the current epidemic.

作者信息

Morillo Carlos A, Banerjee Amitava, Perel Pablo, Wood David, Jouven Xavier

机构信息

Department of Cardiac Sciences, Division of Cardiology, Libin Cardiovascular Institute, University of Calgary, Calgary, AB, Canada.

Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada.

出版信息

J Geriatr Cardiol. 2017 Mar;14(3):195-203. doi: 10.11909/j.issn.1671-5411.2017.03.011.

DOI:10.11909/j.issn.1671-5411.2017.03.011
PMID:28592963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5460066/
Abstract

Atrial fibrillation (AF) is the most common arrhythmia diagnosed in clinical practice. The consequences of AF have been clearly established in multiple large observational cohort studies and include increased stroke and systemic embolism rates if no oral anticoagulation is prescribed, with increased morbidity and mortality. With the worldwide aging of the population characterized by a large influx of "baby boomers" with or without risk factors for developing AF, an epidemic is forecasted within the next 10 to 20 years. Although not all studies support this evidence, it is clear that AF is on the rise and a significant amount of health resources are invested in detecting and managing AF. This review focuses on the worldwide burden of AF and reviews global health strategies focused on improving detection, prevention and risk stratification of AF, recently recommended by the World Heart Federation.

摘要

心房颤动(AF)是临床实践中诊断出的最常见心律失常。多项大型观察性队列研究已明确证实AF的后果,包括在未开具口服抗凝药的情况下,中风和全身性栓塞发生率增加,发病率和死亡率也随之上升。随着全球人口老龄化,大量“婴儿潮一代”涌入,无论有无发生AF的风险因素,预计未来10至20年内将出现AF流行。尽管并非所有研究都支持这一证据,但AF明显呈上升趋势,并且在检测和管理AF方面投入了大量卫生资源。本综述重点关注全球AF负担,并回顾世界心脏联盟最近推荐的旨在改善AF检测、预防和风险分层的全球卫生战略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/cce240817414/jgc-14-03-195-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/d19a5a50252f/jgc-14-03-195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/7106f9cc6b2f/jgc-14-03-195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/9dd1d67de698/jgc-14-03-195-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/aac2b725fa91/jgc-14-03-195-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/cce240817414/jgc-14-03-195-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/d19a5a50252f/jgc-14-03-195-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/7106f9cc6b2f/jgc-14-03-195-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/9dd1d67de698/jgc-14-03-195-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/aac2b725fa91/jgc-14-03-195-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3396/5460066/cce240817414/jgc-14-03-195-g005.jpg

相似文献

1
Atrial fibrillation: the current epidemic.心房颤动:当前的流行疾病
J Geriatr Cardiol. 2017 Mar;14(3):195-203. doi: 10.11909/j.issn.1671-5411.2017.03.011.
2
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.肾功能障碍作为非瓣膜性心房颤动患者中风和全身性栓塞的预测因子:ROCKET AF(利伐沙班每日一次,口服,直接 Xa 因子抑制与维生素 K 拮抗剂预防中风和房颤试验)和 ATRIA(心房颤动抗凝和危险因素)研究队列中 R(2)CHADS(2)指数的验证。
Circulation. 2013 Jan 15;127(2):224-32. doi: 10.1161/CIRCULATIONAHA.112.107128. Epub 2012 Dec 3.
3
Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation.房颤负荷与房颤类型:临床意义及对卒中风险和长期抗凝决策的影响
Vascul Pharmacol. 2016 Aug;83:26-35. doi: 10.1016/j.vph.2016.03.006. Epub 2016 May 16.
4
The Translation of Knowledge Into Practice in the Management of Atrial Fibrillation in Singapore.新加坡心房颤动管理中知识向实践的转化
Heart Lung Circ. 2019 Apr;28(4):605-614. doi: 10.1016/j.hlc.2018.02.024. Epub 2018 Mar 12.
5
Efficacy of anticoagulation for stroke prevention and risk stratification in atrial fibrillation: translating trials into clinical practice.心房颤动中抗凝预防卒中的疗效及风险分层:将试验转化为临床实践
Am J Manag Care. 2004 Apr;10(3 Suppl):S58-65.
6
Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.医疗补助计划覆盖的房颤患者的临床特征、口服抗凝模式及转归:来自房颤更明智治疗转归登记研究(ORBIT-AF I)登记处的见解
J Am Heart Assoc. 2016 May 4;5(5):e002721. doi: 10.1161/JAHA.115.002721.
7
Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.评估口服抗凝药减少中国经器械检测发现的无症状性心房颤动患者血栓栓塞事件(ART-CAF)试验的原理和设计:一项基于开放性登记的临床试验。
Cardiovasc Drugs Ther. 2018 Aug;32(4):389-396. doi: 10.1007/s10557-018-6807-9.
8
The World Heart Federation Roadmap for Nonvalvular Atrial Fibrillation.世界心脏联合会非瓣膜性心房颤动路线图。
Glob Heart. 2017 Dec;12(4):273-284. doi: 10.1016/j.gheart.2017.01.015. Epub 2017 Mar 21.
9
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).心房颤动合并心脏瓣膜病的抗栓治疗:欧洲心律协会(EHRA)和欧洲心脏病学会血栓工作组的联合共识文件,得到 ESC 心脏瓣膜病工作组、南非心脏协会(SA Heart)、心律学会(HRS)、亚太心律学会(APHRS)、南非心脏协会(SA Heart)和拉丁美洲心脏刺激和电生理学会(SOLEACE)的认可。
Europace. 2017 Nov 1;19(11):1757-1758. doi: 10.1093/europace/eux240.
10
Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial.使用植入式循环记录仪连续心电图监测检测心房颤动以预防高危个体中风(LOOP研究):一项大型随机对照试验的原理与设计
Am Heart J. 2017 May;187:122-132. doi: 10.1016/j.ahj.2017.02.017. Epub 2017 Feb 20.

引用本文的文献

1
Effect of recurrence in the blanking period after thoracoscopic atrial fibrillation ablation on long-term recurrence.胸腔镜下房颤消融术后空白期复发对远期复发的影响。
J Cardiothorac Surg. 2025 Aug 9;20(1):330. doi: 10.1186/s13019-025-03573-w.
2
Photoplethysmography in recent-onset atrial fibrillation: automatic detection of rhythm change and burden.近期发作的心房颤动中的光电容积脉搏波描记术:节律变化和负荷的自动检测
Eur Heart J Digit Health. 2025 May 23;6(4):723-732. doi: 10.1093/ehjdh/ztaf055. eCollection 2025 Jul.
3
Miniaturized side-firing intracardiac photoacoustic imaging catheter for monitoring radiofrequency ablation.

本文引用的文献

1
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.《加拿大心血管学会心房颤动管理指南2016年重点更新》
Can J Cardiol. 2016 Oct;32(10):1170-1185. doi: 10.1016/j.cjca.2016.07.591. Epub 2016 Sep 6.
2
Stroke prevention in atrial fibrillation.心房颤动的卒中预防。
Lancet. 2016 Aug 20;388(10046):806-17. doi: 10.1016/S0140-6736(16)31257-0.
3
Association of Cardiovascular Disease and Sleep Apnea at Different Altitudes.不同海拔高度下心血管疾病与睡眠呼吸暂停的关联
用于监测射频消融的小型化侧向发射心内光声成像导管
Sci Rep. 2025 May 20;15(1):17427. doi: 10.1038/s41598-025-98970-5.
4
Design and Evaluation of ACAFiB-APP, a clinical decision support system for anticoagulant considerations in patients with atrial fibrillation.ACAFiB-APP的设计与评估,一种用于心房颤动患者抗凝治疗考量的临床决策支持系统。
BMC Cardiovasc Disord. 2025 Mar 8;25(1):166. doi: 10.1186/s12872-025-04615-w.
5
Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?住院治疗能否改善房颤患者的口服抗凝治疗优化情况?
Eur J Clin Invest. 2025 Apr;55(4):e70011. doi: 10.1111/eci.70011. Epub 2025 Feb 14.
6
The Uric Acid-to-High-Density Lipoprotein Cholesterol Ratio: A New Biomarker for Predicting Arrhythmia Recurrence After Atrial Fibrillation Ablation.尿酸与高密度脂蛋白胆固醇比值:预测心房颤动消融术后心律失常复发的新型生物标志物。
J Clin Med. 2024 Dec 23;13(24):7854. doi: 10.3390/jcm13247854.
7
Prevalence of Atrial Fibrillation in Semiurban Nepal: Result From a Community-Based Cross-Sectional Screening.尼泊尔半城市地区心房颤动的患病率:基于社区的横断面筛查结果
Cardiol Res Pract. 2024 Oct 28;2024:1759135. doi: 10.1155/2024/1759135. eCollection 2024.
8
Long-Term Outcomes after Convergent Procedure for Atrial Fibrillation.心房颤动汇聚手术的长期预后
J Clin Med. 2024 Sep 18;13(18):5508. doi: 10.3390/jcm13185508.
9
Association Between Oral Anticoagulant Adherence and Serious Clinical Outcomes in Patients With Atrial Fibrillation: A Long-Term Retrospective Cohort Study.口服抗凝药物治疗依从性与房颤患者严重临床结局的相关性:一项长期回顾性队列研究。
J Am Heart Assoc. 2024 Sep 17;13(18):e035639. doi: 10.1161/JAHA.124.035639. Epub 2024 Sep 9.
10
The value of phenylalanine in predicting atrial fibrillation risk in chronic heart failure.苯丙氨酸在预测慢性心力衰竭患者房颤风险中的价值。
Front Cardiovasc Med. 2024 Aug 20;11:1392548. doi: 10.3389/fcvm.2024.1392548. eCollection 2024.
High Alt Med Biol. 2016 Dec;17(4):336-341. doi: 10.1089/ham.2016.0027. Epub 2016 Aug 16.
4
Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.47 个国家房颤患者发病 1 年后的死亡和卒中发生情况:一项队列研究。
Lancet. 2016 Sep 17;388(10050):1161-9. doi: 10.1016/S0140-6736(16)30968-0. Epub 2016 Aug 8.
5
Oral Anticoagulant Therapy Prescription in Patients With Atrial Fibrillation Across the Spectrum of Stroke Risk: Insights From the NCDR PINNACLE Registry.口服抗凝治疗处方在具有不同卒中风险谱的房颤患者中的应用:来自 NCDR PINNACLE 注册研究的启示。
JAMA Cardiol. 2016 Apr 1;1(1):55-62. doi: 10.1001/jamacardio.2015.0374.
6
The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.心房颤动类型对血栓栓塞、死亡率和出血风险的影响:系统评价和荟萃分析。
Eur Heart J. 2016 May 21;37(20):1591-602. doi: 10.1093/eurheartj/ehw007. Epub 2016 Feb 16.
7
Impact of standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS): Rationale and design of a prospective randomized multicenter study.标准化监测对缺血性卒中患者心房颤动检测的影响(MonDAFIS):一项前瞻性随机多中心研究的原理与设计
Am Heart J. 2016 Feb;172:19-25. doi: 10.1016/j.ahj.2015.10.010. Epub 2015 Oct 21.
8
Adherence to cardiovascular medications in the South Asian population: A systematic review of current evidence and future directions.南亚人群对心血管药物的依从性:当前证据及未来方向的系统评价
World J Cardiol. 2015 Dec 26;7(12):938-47. doi: 10.4330/wjc.v7.i12.938.
9
Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: A systematic review and meta-analysis.检测不规则脉搏和疑似心房颤动方法的准确性:一项系统评价和荟萃分析。
Eur J Prev Cardiol. 2016 Aug;23(12):1330-8. doi: 10.1177/2047487315611347. Epub 2015 Oct 13.
10
Reducing Cardiovascular Mortality Through Prevention and Management of Raised Blood Pressure: A World Heart Federation Roadmap.通过预防和管理高血压降低心血管死亡率:世界心脏联盟路线图
Glob Heart. 2015 Jun;10(2):111-22. doi: 10.1016/j.gheart.2015.04.006.